This market snapshot provides an analysis of the global market for renal denervation devices for the treatment of refractory hypertension (i.e., high blood pressure that does not respond to pharmaceuticals). The market for renal denervation devices includes radiofrequency and ultrasound catheters which are used to ablate the renal nerves.
This market snapshot is intended to provide a high-level overview of the global market for renal denervation devices, with key insights into:
- Unit volumes from 2022 to 2027
- Market forecasts from 2022 to 2027
- Competitive landscape analysis of major competitors
- Insights into key market events for strategies and startups
Companies Mentioned
- Boston Scientific
- Medtronic
- Otsuka/Recor Medical
